Finance & Investment
In this section you will find Finance & Investment market research reports and publications. These provide information on the latest products, news, market growth forecasts, data and business opportunities of value to your organization.
-
Strategies for Managing Pharmaceutical Workforce and Site Reductions: Analysis of legal, productivity, and quality control issues
$3,835.00Published by Business Insights on Aug 3rd, 2010In 2007, due to the impending patent cliff and the consequent need to cut costs, big pharma began for the first time to outsource chemical API manufacturing to China and... Learn More -
Global Top 10 Healthcare Equipment Companies - Industry, Financial and SWOT Analysis
$1,895.00Published by Datamonitor on May 10th, 2010Top 10 Global Health Care Equipment Companies Report: Strategic evaluation of industry and key players’ is a business report that provides a comprehensive view of the global health care equipment industry and its top 10 companies. Learn More -
Royalty Financing Terms and Agreements in Pharma, Biotech and Diagnostics, 2nd edition
$1,995.00Published by CurrentPartnering on May 3rd, 2010The Royalty Financing Terms and Agreements in Pharma, Biotech and Diagnostics report provides detailed understanding and analysis of how and why companies enter royalty financing deals.. Learn More -
Datamonitor Healthcare Products Companies Report - Global Top 10 Pharmaceutical Companies
$1,895.00Published by Datamonitor on Jun 29th, 2009Top 10 Global Pharmaceutical Companies Report: Strategic evaluation of industry and key players’ is a business report that provides a comprehensive view of the pharmaceutical industry and its top 10 companies. Learn More -
Biotech Exit Strategies: Delivering value to investors in a challenging funding market
$3,835.00Published by Business Insights on Jun 22nd, 2009Establishing the most effective route to exit for a biotech venture is critical in ensuring value is maximized for key stakeholders and the associated technology. However, more critical than selection of exit strategy is the planning and effective execution of exit. Learn More -
Stakeholder Opinions: Diabetic Renal Disease
$3,800.00Published by Datamonitor on Nov 5th, 2008In-depth analysis on the latest challenges, trends and developments in diagnosis, pharmacological and non- pharmacological treatment of Diabetic Renal Disease. Learn More -
Partneringreview 2006 Vol 3 Ch 5: Financing - Public offering (PR06V3C05)
$795.00Published by on Feb 1st, 2006Identify the financing trends in 2005 Learn More -
Partneringreview 2006 Vol 3 Ch 3: Financing - Private placement (PR06V3C03)
$795.00Published by on Feb 1st, 2006Identify the financing trends in 2005 Learn More -
Partneringreview 2006 Vol 3 Ch 1: Financing - Grant/Award (PR06V3C01)
$795.00Published by on Feb 1st, 2006Identify the financing trends in 2005 Learn More -
Partneringreview 2006 - Financings (volume 3)
$2,495.00Published by on Feb 1st, 2006Identify the financing trends in 2005 Learn More -
Partneringreview 2006 Vol 3 Ch 4: Financing - IPO (PR06V3C04)
$795.00Published by on Feb 1st, 2006Identify the financing trends in 2005 Learn More -
Partneringreview 2006 Vol 3 Ch 2: Financing - Equity investment (PR06V3C02)
$795.00Published by on Feb 1st, 2006Identify the financing trends in 2005 Learn More -
ICT Opportunities in European Financial Services: Investment drivers, targeting strategies and the leading players
$1,910.00Published by Business Insights on Aug 5th, 2005The global economic downturn and equity market decline since the late 1990s badly affected the entire financial services industry and resulted in dramatic cuts in IT spending. Learn More -
Alternative Financial Solution for Medical Technology Acquisition
$4,486.00Published by HBS Consulting on May 1st, 2005This strategy review considers the types of alternative financing deployed within the medical devices sector Learn More -
Consumer-Targeted Internet Investment: Online strategies to improve patient care and product positioning
$2,875.00Published by Business Insights on May 3rd, 2003This report will demonstrate how, by empowering the consumer through eBusiness investment, you will deliver the best results for specific promotional campaigns and the corporate branding of your company and products. Learn More
Finance & Investment
In this section you will find Finance & Investment market research reports and publications. These provide information on the latest products, news, market growth forecasts, data and business opportunities of value to your organization.
-
Strategies for Managing Pharmaceutical Workforce and Site Reductions: Analysis of legal, productivity, and quality control issues
$3,835.00Published by Business Insights on Aug 3rd, 2010In 2007, due to the impending patent cliff and the consequent need to cut costs, big pharma began for the first time to outsource chemical API manufacturing to China and... Learn More -
Global Top 10 Healthcare Equipment Companies - Industry, Financial and SWOT Analysis
$1,895.00Published by Datamonitor on May 10th, 2010Top 10 Global Health Care Equipment Companies Report: Strategic evaluation of industry and key players’ is a business report that provides a comprehensive view of the global health care equipment industry and its top 10 companies. Learn More -
Royalty Financing Terms and Agreements in Pharma, Biotech and Diagnostics, 2nd edition
$1,995.00Published by CurrentPartnering on May 3rd, 2010The Royalty Financing Terms and Agreements in Pharma, Biotech and Diagnostics report provides detailed understanding and analysis of how and why companies enter royalty financing deals.. Learn More -
Datamonitor Healthcare Products Companies Report - Global Top 10 Pharmaceutical Companies
$1,895.00Published by Datamonitor on Jun 29th, 2009Top 10 Global Pharmaceutical Companies Report: Strategic evaluation of industry and key players’ is a business report that provides a comprehensive view of the pharmaceutical industry and its top 10 companies. Learn More -
Biotech Exit Strategies: Delivering value to investors in a challenging funding market
$3,835.00Published by Business Insights on Jun 22nd, 2009Establishing the most effective route to exit for a biotech venture is critical in ensuring value is maximized for key stakeholders and the associated technology. However, more critical than selection of exit strategy is the planning and effective execution of exit. Learn More -
Stakeholder Opinions: Diabetic Renal Disease
$3,800.00Published by Datamonitor on Nov 5th, 2008In-depth analysis on the latest challenges, trends and developments in diagnosis, pharmacological and non- pharmacological treatment of Diabetic Renal Disease. Learn More -
Partneringreview 2006 Vol 3 Ch 5: Financing - Public offering (PR06V3C05)
$795.00Published by on Feb 1st, 2006Identify the financing trends in 2005 Learn More -
Partneringreview 2006 Vol 3 Ch 3: Financing - Private placement (PR06V3C03)
$795.00Published by on Feb 1st, 2006Identify the financing trends in 2005 Learn More -
Partneringreview 2006 Vol 3 Ch 1: Financing - Grant/Award (PR06V3C01)
$795.00Published by on Feb 1st, 2006Identify the financing trends in 2005 Learn More -
Partneringreview 2006 - Financings (volume 3)
$2,495.00Published by on Feb 1st, 2006Identify the financing trends in 2005 Learn More -
Partneringreview 2006 Vol 3 Ch 4: Financing - IPO (PR06V3C04)
$795.00Published by on Feb 1st, 2006Identify the financing trends in 2005 Learn More -
Partneringreview 2006 Vol 3 Ch 2: Financing - Equity investment (PR06V3C02)
$795.00Published by on Feb 1st, 2006Identify the financing trends in 2005 Learn More -
ICT Opportunities in European Financial Services: Investment drivers, targeting strategies and the leading players
$1,910.00Published by Business Insights on Aug 5th, 2005The global economic downturn and equity market decline since the late 1990s badly affected the entire financial services industry and resulted in dramatic cuts in IT spending. Learn More -
Alternative Financial Solution for Medical Technology Acquisition
$4,486.00Published by HBS Consulting on May 1st, 2005This strategy review considers the types of alternative financing deployed within the medical devices sector Learn More -
Consumer-Targeted Internet Investment: Online strategies to improve patient care and product positioning
$2,875.00Published by Business Insights on May 3rd, 2003This report will demonstrate how, by empowering the consumer through eBusiness investment, you will deliver the best results for specific promotional campaigns and the corporate branding of your company and products. Learn More

